The home of the Audio Journal of Oncology

Maraviroc for HIV: Responses at 48 Weeks

AudioMedica News
AudioMedica News
Maraviroc for HIV: Responses at 48 Weeks
Maraviroc for HIV: Responses at 48 Weeks
/
Jacob Lalezari
Jacob Lalezari

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JACOB LALEZARI, Quest Clinical Research, San Francisco
Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of Quest Clinical Research in San Francisco. He presented 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him at ICAAC in Chicago.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070918JacobLalezari.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality